Nimodipine is indicated for the treatment of ischaemic neurological deficits following aneurysmal subarachnoid haemorrhage.
Nimodipine is indicated for the prevention of ischaemic neurological deficits following aneurysmal subarachnoid haemorrhage.
0.9% isotonic saline solution is indicated : • for fluid replacement and provision of extracellular ions in near physiological concentration in conditions of extracellular-volume depletion, dehydration and electrolyte imbalance such as sodium depletion • as an isotonic medium for intravenous administration of medicinal products known to be compatible with 0.9% sodium chloride.
Hyaluronidase can be used to enhance permeation of subcutaneous or intramuscular injections, local anaesthetics and subcutaneous infusions and to promote resorption of excess fluids and blood in the tissues.
Takeda announced that the FDA has approved Gammagard Liquid[Immune Globulin Infusion (Human) 10% solution] as an intravenous immunoglobulin (IVIG) therapy to improve neuromuscular disability and impairment in adults with chronic inflammatory demyelinating polyneuropathy (CIDP)
Intravenous (IV) Adenosine 30mg/10ml Solution for Infusion is a coronary vasodilator, for use in conjunction with radionuclide myocardial perfusion imaging, in patients who cannot exercise adequately or for whom exercise is inappropriate. Adenosine 30mg/10ml Solution for Infusion is indicated in adults.
Glucose 10% w/v Solution for Infusion is indicated for: Supply of carbohydrate alone or, as required, during parenteral nutrition. Prevention and treatment of hypoglycaemia. Rehydration in case of water loss and dehydration states in patients with high carbohydrate need. Dilution of compatible medicinal products.
Noxafil concentrate for solution for infusion is indicated for use in the treatment of the following fungal infections in adults (see section 5.1): - Invasive aspergillosis in patients with disease that is refractory to amphotericin B or itraconazole or in patients who are intolerant of these medicinal products; - Fusariosis in patients with disease that is refractory to amphotericin B or in patients who are intolerant of amphotericin B; - Chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole; - Coccidioidomycosis in patients with disease that is refractory to amphotericin B, itraconazole or fluconazole or in patients who are intolerant of these medicinal products. Refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective antifungal therapy . Noxafil concentrate for solution for infusion is also indicated for prophylaxis of invasive fungal infections in the following patients: - Patients receiving remission-induction chemotherapy for acute myelogenous leukemia (AML) or myelodysplastic syndromes (MDS) expected to result in prolonged neutropenia and who are at high risk of developing invasive fungal infections; - Hematopoietic stem cell transplant (HSCT) recipients who are undergoing high-dose immunosuppressive therapy for graft versus host disease (GVHD) and who are at high risk of developing invasive fungal infections. Please refer to the Summary of Product Characteristics of Noxafil oral suspension for use in oropharyngeal candidiasis.
5% Glucose Intravenous Infusion Solution is indicated for: • fluid replacement, administered alone or in regimens with electrolytes or additives known to be compatible with 5% glucose. • medium for intravenous administration of medicinal products known to be compatible with 5% glucose.
Sterile Potassium Chloride 20% w/v Concentrate for Solution for Infusion is used as a source of the potassium cation for the treatment or prevention of potassium depletion in patients for whom dietary measures or oral medication are inadequate. Potassium salts may also be used cautiously in those taking digoxin where potassium depletion may cause arrhythmias. Sterile Potassium Chloride 20% w/v Concentrate for Solution for Infusion